The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis
Open accessAbstract
Pyruvate kinase plays a pivotal role in regulating cell metabolism. The final and rate-limiting step of glycolysis is the conversion of Phosphoenolpyruvate (PEP) to Pyruvate, which is catalyzed by Pyruvate Kinase. There are four isomeric, tissue-specific forms of Pyruvate Kinase found in mammals: PKL, PKR, PKM1, and PKM2. PKM1 and PKM2 are formed bya single mRNA transcript of the PKM gene by alternative splicing. The oligomers of PKM2 exist in high activity tetramer and low activity dimer forms. The dimer PKM2 regulates the rate-limiting step of glycolysis that shifts the glucose metabolism from the normal respiratory chain to lactate production in tumor cells. Besides its role as a metabolic regulator, it also acts as protein kinase, which contributes to tumorigenesis. This review is focused on the metabolic role of pyruvate kinase M2 in normal cells vs. cancerous cells and its regulation at the transcriptional level. The review also highlights the role of PKM2 as a potential diagnostic marker and as a therapeutic target in cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
Targeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
Glutamine and cancer: cell biology, physiology, and clinical opportunities
Hensley, C. T., Wasti, A. T., & DeBerardinis, R. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69600 · Cited by 1,262 · cited 1×
“Glutamine is the most abundant amino acid found in the blood and is involved in many aspects of cancer metabolism (87).”
BackgroundEvidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.
Reitzer, L. J., Wice, B. M., & Kennell, D. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30124-2 · Cited by 1,240
Anastasiou, D., Poulogiannis, G., Asara, J. M., Boxer, M. B., Jiang, J.-K., Shen, M., Bellinger, G., Sasaki, A. T., Locasale, J. W., Auld, D. S., et al. (2011) · Science · doi:10.1126/science.1211485 · Cited by 1,190
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179
Targeting metabolic transformation for cancer therapy
Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2817 · Cited by 1,059
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Yang, W., Xia, Y., Ji, H., Zheng, Y., Liang, J., Huang, W., Gao, X., Aldape, K., & Lu, Z. (2011) · Nature · doi:10.1038/nature10598 · Cited by 1,028
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
McAllister, S. S., & Weinberg, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3015 · Cited by 966
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
Yang, W., Zheng, Y., Xia, Y., Ji, H., Chen, X., Guo, F., Lyssiotis, C. A., Aldape, K., Cantley, L. C., & Lu, Z. (2012) · Nature Cell Biology · doi:10.1038/ncb2629 · Cited by 918
PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis
Yang, W., Xia, Y., Hawke, D., Li, X., Liang, J., Xing, D., Aldape, K., Hunter, T., Alfred Yung, W. K., & Lu, Z. (2012) · Cell · doi:10.1016/j.cell.2012.07.018 · Cited by 846
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Anastasiou, D., Yu, Y., Israelsen, W. J., Jiang, J.-K., Boxer, M. B., Hong, B. S., Tempel, W., Dimov, S., Shen, M., Jha, A., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1060 · Cited by 816
Pyruvate kinase type M2 and its role in tumor growth and spreading
Mazurek, S., Boschek, C. B., Hugo, F., & Eigenbrodt, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.009 · Cited by 812
Uptake and Metabolism of Plasma Glutamine by the Small Intestine
Windmueller, H. G., & Spaeth, A. E. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42329-6 · Cited by 790
Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth
Hitosugi, T., Kang, S., Vander Heiden, M. G., Chung, T.-W., Elf, S., Lythgoe, K., Dong, S., Lonial, S., Wang, X., Chen, G. Z., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000431 · Cited by 784
Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
Mazurek, S. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.02.005 · Cited by 694
Serine is a natural ligand and allosteric activator of pyruvate kinase M2
Chaneton, B., Hillmann, P., Zheng, L., Martin, A. C. L., Maddocks, O. D. K., Chokkathukalam, A., Coyle, J. E., Jankevics, A., Holding, F. P., Vousden, K. H., et al. (2012) · Nature · doi:10.1038/nature11540 · Cited by 661
Lv, L., Li, D., Zhao, D., Lin, R., Chu, Y., Zhang, H., Zha, Z., Liu, Y., Li, Z., Xu, Y., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.025 · Cited by 610
Sun, Q., Chen, X., Ma, J., Peng, H., Wang, F., Zha, X., Wang, Y., Jing, Y., Yang, H., Chen, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014769108 · Cited by 586
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells
Israelsen, W. J., Dayton, T. L., Davidson, S. M., Fiske, B. P., Hosios, A. M., Bellinger, G., Li, J., Yu, Y., Sasaki, M., Horner, J. W., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.025 · Cited by 549
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
Chen, J., Xie, J., Jiang, Z., Wang, B., Wang, Y., & Hu, X. (2011) · Oncogene · doi:10.1038/onc.2011.137 · Cited by 512
Qi, W., Keenan, H. A., Li, Q., Ishikado, A., Kannt, A., Sadowski, T., Yorek, M. A., Wu, I.-H., Lockhart, S., Coppey, L. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4328 · Cited by 479
Clower, C. V., Chatterjee, D., Wang, Z., Cantley, L. C., Vander Heiden, M. G., & Krainer, A. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914845107 · Cited by 424
PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation
Azoitei, N., Becher, A., Steinestel, K., Rouhi, A., Diepold, K., Genze, F., Simmet, T., & Seufferlein, T. (2016) · Molecular Cancer · doi:10.1186/s12943-015-0490-2 · Cited by 336
Lv, L., Xu, Y.-P., Zhao, D., Li, F.-L., Wang, W., Sasaki, N., Jiang, Y., Zhou, X., Li, T.-T., Guan, K.-L., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.004 · Cited by 334
Human pyruvate kinase M2: A multifunctional protein
Gupta, V., & Bamezai, R. N. K. (2010) · Protein Science · doi:10.1002/pro.505 · Cited by 317
Wei, Y., Wang, D., Jin, F., Bian, Z., Li, L., Liang, H., Li, M., Shi, L., Pan, C., Zhu, D., et al. (2017) · Nature Communications · doi:10.1038/ncomms14041 · Cited by 315
Tamada, M., Nagano, O., Tateyama, S., Ohmura, M., Yae, T., Ishimoto, T., Sugihara, E., Onishi, N., Yamamoto, T., Yanagawa, H., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3024 · Cited by 275
No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
Bluemlein, K., Grüning, N.-M., Feichtinger, R. G., Lehrach, H., Kofler, B., & Ralser, M. (2011) · Oncotarget · doi:10.18632/oncotarget.278 · Cited by 253
Yang, W., Xia, Y., Cao, Y., Zheng, Y., Bu, W., Zhang, L., You, M. J., Koh, M. Y., Cote, G., Aldape, K., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.028 · Cited by 245
PKM2, a Central Point of Regulation in Cancer Metabolism
Wong, N., De Melo, J., & Tang, D. (2013) · International Journal of Cell Biology · doi:10.1155/2013/242513 · Cited by 243
Identification of small molecule inhibitors of pyruvate kinase M2
Vander Heiden, M. G., Christofk, H. R., Schuman, E., Subtelny, A. O., Sharfi, H., Harlow, E. E., Xian, J., & Cantley, L. C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.003 · Cited by 237
Kefas, B., Comeau, L., Erdle, N., Montgomery, E., Amos, S., & Purow, B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq080 · Cited by 235
Hamabe, A., Konno, M., Tanuma, N., Shima, H., Tsunekuni, K., Kawamoto, K., Nishida, N., Koseki, J., Mimori, K., Gotoh, N., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407717111 · Cited by 234
Iansante, V., Choy, P. M., Fung, S. W., Liu, Y., Chai, J.-G., Dyson, J., Del Rio, A., D’Santos, C., Williams, R., Chokshi, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8882 · Cited by 233
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
Goldberg, M. S., & Sharp, P. A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111487 · Cited by 230
Keller, K. E., Tan, I. S., & Lee, Y.-S. (2012) · Science · doi:10.1126/science.1224409 · Cited by 228
Lee, J., Kim, H. K., Han, Y.-M., & Kim, J. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.009 · Cited by 214
EIGENBRODT, E., Reinacher, M., Scheefers-Borchel, U., SCHEEFERS, H., & Friis, R. R. (1992) · PubMed · Cited by 210
Small molecule activation of PKM2 in cancer cells induces serine auxotrophy
Kung, C., Hixon, J., Choe, S., Marks, K., Gross, S., Murphy, E., DeLaBarre, B., Cianchetta, G., Sethumadhavan, S., Wang, X., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.021 · Cited by 192
Keller, K. E., Doctor, Z. M., Dwyer, Z. W., & Lee, Y.-S. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.02.015 · Cited by 179
The multifaceted regulation and functions of PKM2 in tumor progression
Li, Z., Yang, P., & Li, Z. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.07.008 · Cited by 175
Protein kinase C family: On the crossroads of cell signaling in skin and tumor epithelium
Breitkreutz, D., Braiman, L., Schneider‐Daum, N., Denning, M. F., & Tennenbaum, T. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0280-3 · Cited by 169
Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth
Xiangyun, Y., Xiaomin, N., linping, G., Yunhua, X., Ziming, L., Yongfeng, Y., Zhiwei, C., & Shun, L. (2017) · Oncotarget · doi:10.18632/oncotarget.14346 · Cited by 164
Rosa, V. D., Iommelli, F., Monti, M., Fonti, R., Votta, G., Stoppelli, M. P., & Vecchio, S. D. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0375 · Cited by 159
NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase
Gu, Z., Xia, J., Xu, H., Frech, I., Tricot, G. J. K., & Zhan, F. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0392-4 · Cited by 157
Luan, W., Wang, Y., Chen, X., Shi, Y., Wang, J., Zhang, J., Qian, J., Li, R., Tao, T., Wei, W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3514 · Cited by 155
Ding, S., Li, Y., Shao, X., Zhou, H., Zeng, R., Tang, Z., & Xia, Q. (2004) · PROTEOMICS · doi:10.1002/pmic.200300653 · Cited by 154
Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis
Zhao, X., Zhu, Y., Hu, J., Jiang, L., Li, L., Jia, S., & Zen, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-31615-y · Cited by 154
PPARγ contributes to PKM2 and HK2 expression in fatty liver
Panasyuk, G., Espeillac, C., Chauvin, C., Pradelli, L. A., Horie, Y., Suzuki, A., Annicotte, J., Fajas, L., Foretz, M., Verdeguer, F., et al. (2012) · Nature Communications · doi:10.1038/ncomms1667 · Cited by 152
Pyruvate kinase M2 facilitates colon cancer cell migration via the modulation of STAT3 signalling
Yang, P., Li, Z., Fu, R., Wu, H., & Li, Z. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.03.020 · Cited by 145
Amin, S., Yang, P., & Li, Z. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.02.003 · Cited by 134
Allosteric Regulation of PKM2 Allows Cellular Adaptation to Different Physiological States
Gui, D. Y., Lewis, C. A., & Heiden, M. G. V. (2013) · Science Signaling · doi:10.1126/scisignal.2003925 · Cited by 129
Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression
Xu, Q., Liu, L.-Z., Yin, Y., He, J., Li, Q., Qian, X., You, Y., Lu, Z., Peiper, S. C., Shu, Y., et al. (2015) · Oncogene · doi:10.1038/onc.2015.6 · Cited by 121
Ning, X., Qi, H., Li, R., Li, Y., Jin, Y., McNutt, M. A., Liu, J., & Yin, Y. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.064 · Cited by 118
Iqbal, M. A., Siddiqui, F. A., Gupta, V., Chattopadhyay, S., Prakasam, G., Kumar, B., Manvati, S., Chaman, N., & Bamezai, R. N. K. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-72 · Cited by 117
Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice
Shi, H., Li, D., Zhang, J., Wang, Y., Li, Y., Zhang, H., Wang, X., Mu, B., Wang, W., Ma, Y., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01562.x · Cited by 114
Liu, W.-R., Tian, M., Yang, L., Lin, Y., Jin, L., Ding, Z., Shen, Y., Peng, Y., Gao, D., Zhou, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2749 · Cited by 107
PKM2, a potential target for regulating cancer
Li, Y., Li, X., Liu, J., Wang, H., Fan, L., Li, J., & Sun, G. (2018) · Gene · doi:10.1016/j.gene.2018.05.038 · Cited by 106
Spoden, G. A., Rostek, U., Lechner, S. G., Mitterberger, M. C., Mazurek, S., & Zwerschke, W. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.06.024 · Cited by 101
Zhang, L., Lou, J., Lü, M., Gao, C., Zhao, S., Li, B., Liang, S., Li, Y., Li, D., & Liu, M. (2015) · The EMBO Journal · doi:10.15252/embj.201591803 · Cited by 101
Cytosolic thyroid hormone-binding protein is a monomer of pyruvate kinase.
Kato, H., Fukuda, T., Parkison, C., McPhie, P., & Cheng, S.-Y. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7861 · Cited by 99
Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model
Guo, W., Zhang, Y., Chen, T., Wang, Y., Xue, J., Zhang, Y., Xiao, W., Mo, X., & Lü, Y. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0860-5 · Cited by 99
Wang, C., Zhang, S., Liu, J., Tian, Y., Ma, B., Xu, S., Fu, Y., & Luo, Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.037 · Cited by 97
Pyruvate Kinase M2 in Blood Circulation Facilitates Tumor Growth by Promoting Angiogenesis
Li, L., Zhang, Y., Qiao, J., Yang, J. J., & Liu, Z. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.576934 · Cited by 95
Fecal M2-pyruvate kinase (M2-PK): A novel marker of intestinal inflammation
Chung‐Faye, G., Hayee, B., Maestranzi, S., Donaldson, N., Forgács, I., & Sherwood, R. A. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20214 · Cited by 89
選択的スプライシングレプレッサーhnRNP A1/A2とPTBはピルビン酸キナーゼアイソフォーム発現と細胞代謝に影響する
Cynthia, V. C., Deblina, C., Zhenxun, W., Cantley, L. C., Matthew, G. V. H., & Adrian, R. (2010) · Cited by 82
Schneider, J., Neu, K., Grimm, H., Velcovsky, H. G., Weisse, G., & EIGENBRODT, E. (2002) · PubMed · Cited by 79
Mazurek, S. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2008_091 · Cited by 78
L- and M2- pyruvate kinase expression in renal cell carcinomas and their metastases
Brinck, U., Fischer, G., EIGENBRODT, E., Oehmke, M. J., & Mazurek, S. (1994) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00193498 · Cited by 77
Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth
Parnell, K. M., Foulks, J. M., Nix, R. N., Clifford, A., Bullough, J., LUO, B. H., Senina, A. V., Vollmer, D., Liu, J., McCarthy, V., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0026 · Cited by 76
Gao, X., Wang, H., Yang, J. J., Chen, J., Jie, J., Li, L., Zhang, Y., & Liu, Z. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.448753 · Cited by 72
Feng, C., Gao, Y. L., Wang, C., Yu, X., Zhang, W., Guan, H., Shan, Z., & Teng, W. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4258 · Cited by 72
Witney, T. H., James, M. L., Shen, B., Chang, E., Pohling, C., Arksey, N., Höhne, A., Shuhendler, A. J., Park, J. H., Bodapati, D., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac6117 · Cited by 67
Papadaki, C., Sfakianaki, M., Lagoudaki, E. D., Giagkas, G., Ioannidis, G., Trypaki, M., Tsakalaki, E., Voutsina, A., Koutsopoulos, A. V., Mavroudis, D., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.492 · Cited by 65
Guo, M., Zhao, X., Yuan, X., Jiang, J., & Li, P. (2017) · Oncotarget · doi:10.18632/oncotarget.15999 · Cited by 63
Cytosolic PKM2 stabilizes mutant EGFR protein expression through regulating HSP90–EGFR association
Yang, Y., Cheng, T.-Y., Huang, S.-M., Su, C., Yang, P.-W., Lee, J.-M., Chen, C.-K., Hsiao, M., Hua, K.-T., & Kuo, M.-L. (2015) · Oncogene · doi:10.1038/onc.2015.397 · Cited by 62
Yang, L., Lv, F., Liu, F., Guo, X., Fan, Y., Gu, F., Gu, J., & Fu, L. (2015) · Journal of Cancer · doi:10.7150/jca.12719 · Cited by 53
NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells
Han, D., Wei, W., Chen, X., Zhang, Y., Wang, Y., Zhang, J., Wang, X., Yu, T., Hu, Q., Liu, N., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4444 · Cited by 53
Yang, Y., Cheng, T.-Y., Huang, S.-M., Su, C., Yang, P.-W., Lee, J.-M., Chen, C.-K., Hsiao, M., Hua, K.-T., & Kuo, M.-L. (2017) · Oncogene · doi:10.1038/onc.2017.18 · Cited by 49
PKM2 and HIF-1α regulation in prostate cancer cell lines
Hasan, D., Gamen, E., Tarboush, N. A., Ismail, Y. H. M., Pak, O., & Azab, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203745 · Cited by 48
Ning, X., Qi, H., Li, R., Jin, Y., McNutt, M. A., & Yin, Y. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1404591 · Cited by 47
Overexpression of PKM2 promotes mitochondrial fusion through attenuated p53 stability
Wu, H., Yang, P., Hu, W., Wang, Y., Lu, Y., Zhang, L., Fan, Y., Xiao, H., & Li, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.12942 · Cited by 41
M2-PK as a novel marker in ovarian cancer. A prospective cohort study.
Ahmed, A. S., Dew, T. K., Lawton, F., Papadopoulos, A., Devaja, O., Raju, K. S., & Sherwood, R. A. (2007) · PubMed · Cited by 36
On/Off-regulation of phospholipase C-γ1-mediated signal transduction
Choi, J. H., Ryu, S. H., & Suh, P. (2007) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.12.010 · Cited by 34
Panchabhai, S. C., Schlam, I. M., Sebastian, S., et al. (2016) · Leukemia · doi:10.1038/leu.2016.389 · Cited by 34
Prolactin Inhibits Activity of Pyruvate Kinase M2 to Stimulate Cell Proliferation
Varghese, B., Swaminathan, G., Plotnikov, A., Tzimas, C., Yang, N., Rui, H., & Fuchs, S. Y. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0219 · Cited by 27
Cited by
NRF2, a Transcription Factor for Stress Response and Beyond
He, F., Ru, X., & Wen, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134777 · Cited by 1,820
Revisiting the Warburg effect: historical dogma versus current understanding
Vaupel, P., & Multhoff, G. (2021) · The Journal of Physiology · doi:10.1113/jp278810 · Cited by 830
LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer
Tan, Y., Lin, J., Li, T., Li, J., Xu, R., & Ju, H. (2021) · Cancer Communications · doi:10.1002/cac2.12108 · Cited by 700
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Tufail, M., Jiang, C.-H., & Li, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02119-3 · Cited by 534
The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer
Wang, J., Zhu, W., Han, J., Yang, X., Zhou, R., Lu, H., Yu, H., Yuan, W., Li, P., Tao, J., et al. (2021) · Cancer Communications · doi:10.1002/cac2.12158 · Cited by 313
Metadata
- Authors
- Zahra, K., Dey, T., Ashish, Mishra, S. P., & Pandey, U.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-03-02
- Volume
- 10
- Pages
- 159-159
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3010320114
- Cited by
- 501
- References
- 92
- FWCI
- 20.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.